
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Oncology, Markers, Clinical Correlates |
Department of Pathology, Josephine Nefkens Institute [H. D., W. N. M. D., M. A., R. R. d. K.] and Departments of Surgery [H. v. U., D. M.] and Otorhinolaryngology [B. K. H. P.], Erasmus Medical Center, 1738 Rotterdam, the Netherlands, and Department of Pathology, Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands [W. J. M.]
Purpose: Recently, familial paraganglioma (PGL) was shown to be caused bymutations in the gene encoding succinate dehydrogenase subunit D (SDHD). However, the prevalence of SDHD mutations in apparently sporadic PGL is unknown. We studied the frequency and spectrum of germ-line and somatic SDHD mutations in patients with parasympathetic PGL.
Experimental Design: We studied 57 unselected patients who developed parasympathetic PGLs (n = 105 tumors) and who were treated between 1987 and 1999 at the Erasmus MC (Rotterdam, the Netherlands). Thirty-eight (67%) of these patients (n = 51 tumors) lacked a family history of parasympathetic PGL. We used conformation-dependent gel electrophoresis and sequence determination analysis of germ-line and tumor DNA to identify SDHD mutations. We compared the clinical and molecular characteristics of sporadic and hereditary PGLs.
Results: Three different SDHD germ-line mutations were identified in 32 of the 57 (56%) patients. These included 19 of 19 (100%) patients with familial PGL and also 13 of 38 (34%) patients with apparently sporadic PGL. All three mutations were characterized as missense mutations (D92Y, L95P, and L139P) in highly conserved regions of the SDHD gene and were not observed in 200 control alleles. No somatic mutations were found.
Conclusions: Germ-line mutations of the SDHD gene are present in a significant number of patients with apparently sporadic parasympathetic PGL. Somatic SDHD mutations do not play a significant role in the sporadic form of this tumor. Genetic testing for SDHD germ-line mutations should be considered for every patient presenting with this tumor, even if a personal or family history of PGL is absent, to allow appropriate clinical management.
This article has been cited by other articles:
![]() |
J. Lima, T. Feijao, A. Ferreira da Silva, I. Pereira-Castro, G. Fernandez-Ballester, V. Maximo, A. Herrero, L. Serrano, M. Sobrinho-Simoes, and G. Garcia-Rostan High Frequency of Germline Succinate Dehydrogenase Mutations in Sporadic Cervical Paragangliomas in Northern Spain: Mitochondrial Succinate Dehydrogenase Structure-Function Relationships and Clinical-Pathological Correlations J. Clin. Endocrinol. Metab., December 1, 2007; 92(12): 4853 - 4864. [Abstract] [Full Text] [PDF] |
||||
![]() |
L Simi, R Sestini, P Ferruzzi, M S Gagliano, F Gensini, M Mascalchi, L Guerrini, C Pratesi, P Pinzani, G Nesi, et al. Phenotype variability of neural crest derived tumours in six Italian families segregating the same founder SDHD mutation Q109X J. Med. Genet., August 1, 2005; 42(8): e52 - e52. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Dannenberg, F. H. van Nederveen, M. Abbou, A. A. Verhofstad, P. Komminoth, R. R. de Krijger, and W. N.M. Dinjens Clinical Characteristics of Pheochromocytoma Patients With Germline Mutations in SDHD J. Clin. Oncol., March 20, 2005; 23(9): 1894 - 1901. [Abstract] [Full Text] [PDF] |
||||
![]() |
B E Baysal, J E Willett-Brozick, P A A Filho, E C Lawrence, E N Myers, and R E Ferrell An Alu-mediated partial SDHC deletion causes familial and sporadic paraganglioma J. Med. Genet., September 1, 2004; 41(9): 703 - 709. [Full Text] [PDF] |
||||
![]() |
R F Badenhop, J C Jansen, P A Fagan, R S A Lord, Z G Wang, W J Foster, and P R Schofield The prevalence of SDHB, SDHC, and SDHD mutations in patients with head and neck paraganglioma and association of mutations with clinical features J. Med. Genet., July 1, 2004; 41(7): e99 - e99. [Full Text] [PDF] |
||||
![]() |
A Cascon, S Ruiz-Llorente, M F Fraga, R Leton, D Telleria, J Sastre, J Jose Diez, G Martinez Diaz-Guerra, J A Diaz Perez, J Benitez, et al. Genetic and epigenetic profile of sporadic pheochromocytomas J. Med. Genet., March 1, 2004; 41(3): e30 - 30. [Full Text] [PDF] |
||||
![]() |
J. Lima, J. Teixeira-Gomes, P. Soares, V. Maximo, M. Honavar, D. Williams, and M. Sobrinho-Simoes Germline Succinate Dehydrogenase Subunit D Mutation Segregating with Familial Non-RET C Cell Hyperplasia J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4932 - 4937. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Bryant, J. Farmer, L. J. Kessler, R. R. Townsend, and K. L. Nathanson Pheochromocytoma: The Expanding Genetic Differential Diagnosis J Natl Cancer Inst, August 20, 2003; 95(16): 1196 - 1204. [Abstract] [Full Text] [PDF] |
||||
![]() |
C Bauters, M-C Vantyghem, E Leteurtre, M-F Odou, C Mouton, N Porchet, J-L Wemeau, C Proye, and P Pigny Hereditary phaeochromocytomas and paragangliomas: a study of five susceptibility genes J. Med. Genet., June 1, 2003; 40(6): e75 - 75. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |